Safety and factors affecting same‐day discharge following mastectomy and immediate alloplastic reconstruction

Author:

Ghosh Kanad1ORCID,Shakir Afaaf1,Kuchta Kristine2,Seth Akhil2,Sisco Mark2ORCID

Affiliation:

1. Department of Surgery, Section of Plastic and Reconstructive Surgery University of Chicago Pritzker School of Medicine Chicago Illinois USA

2. Department of Surgery, Division of Plastic and Reconstructive Surgery NorthShore University HealthSystem Northbrook Illinois USA

Abstract

AbstractBackground and ObjectivesPatients undergoing breast reconstruction following mastectomy are often admitted overnight. In 2020, our institution implemented a protocol change to discharge clinically stable patients immediately. In this study, we examine the safety of same‐day discharge following mastectomy and reconstruction.MethodsOur retrospective study included female adults undergoing mastectomy and immediate alloplastic reconstruction from August 2019 to January 2020, before implementation of the same‐day discharge protocol, and from March 2020 to September 2021, after the protocol implementation. Independent t‐test and chi‐square analysis was conducted to examine statistical differences.ResultsTwo hundred and eighty‐five patients were included. Forty‐two patients underwent reconstruction before the protocol change (Group 1) and 243 patients underwent reconstruction after the protocol change (Group 2). Group 2 had a greater percentage of prepectoral implant placement. There was no difference in demographics, complications, readmission, or reoperation. Within Group 2, 157 patients were discharged the same day (Group 2a) and 88 patients required overnight admission (Group 2b). Group 2b had higher body mass index, higher percentage of bilateral mastectomy, and larger mastectomy weights. Despite no differences in complications, Group 2b exhibited higher rates of requiring intravenous antibiotics and reoperation.ConclusionsPatients may be safely discharged the same day following mastectomy and alloplastic reconstruction without an increase in complications.

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3